Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
Patient sample and mouse experiments suggest that inhibiting CEBPB could help treat AD. In postmortem brain tissue samples from patients, levels of CEBPB were higher than in samples from unaffected su...
BCIQ Company Profiles
Emory University School of Medicine
Tongji University
Xuanwu Hospital of Capital Medical University
BCIQ Target Profiles
CCAAT enhancer binding protein beta (CEBPB) (CRP2)